ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354 | -13.0% | 17,000 | 0.0% | 0.12% | -10.2% |
| Q2 2023 | $407 | +27.2% | 17,000 | 0.0% | 0.13% | +17.4% |
| Q1 2023 | $320 | +18.1% | 17,000 | 0.0% | 0.11% | +12.4% |
| Q4 2022 | $271 | -99.9% | 17,000 | 0.0% | 0.10% | -4.9% |
| Q3 2022 | $278,000 | +15.8% | 17,000 | 0.0% | 0.10% | +21.4% |
| Q2 2022 | $240,000 | -41.7% | 17,000 | 0.0% | 0.08% | -22.9% |
| Q1 2022 | $412,000 | +3.8% | 17,000 | 0.0% | 0.11% | +14.7% |
| Q4 2021 | $397,000 | +38.8% | 17,000 | -1.2% | 0.10% | +26.7% |
| Q3 2021 | $286,000 | -37.0% | 17,200 | -7.5% | 0.08% | -35.9% |
| Q2 2021 | $454,000 | -1.1% | 18,600 | +4.5% | 0.12% | -8.6% |
| Q1 2021 | $459,000 | -51.8% | 17,800 | 0.0% | 0.13% | -56.3% |
| Q4 2020 | $952,000 | +35.0% | 17,800 | +4.1% | 0.29% | +18.1% |
| Q3 2020 | $705,000 | – | 17,100 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |